Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Risk for severe weather this weekend. The best chance for rain and when storms move in the area
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,179.31
+3.98 (+0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regeneron Pharmaceuticals
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
38
39
Next >
2 Top Stocks to Buy in August and Hold Forever
August 06, 2023
These companies won't disappoint long-term investors.
Via
The Motley Fool
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
August 04, 2023
Via
Benzinga
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
August 04, 2023
Amazon, ELF and CAT were earnings winners, but there were big losers too.
Via
Investor's Business Daily
Regeneron Surmounts Its 200-Day Line On A Handy Second-Quarter Beat
August 03, 2023
Shares have been trapped below their 200-day moving average since late June.
Via
Investor's Business Daily
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Regeneron Pharmaceuticals Earnings Preview
August 02, 2023
Via
Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $58,000 Today
August 01, 2023
Via
Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
August 03, 2023
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90...
Via
Benzinga
Why Is Regeneron Pharmaceuticals Moving Higher Today?
August 03, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre
Via
Benzinga
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.
Via
Benzinga
P/E Ratio Insights for Regeneron Pharmaceuticals
July 28, 2023
Via
Benzinga
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
July 19, 2023
Via
Benzinga
Regeneron Reports Second Quarter 2023 Financial and Operating Results
August 03, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
Regeneron Announces the 2023 Winners of The Regeneron Prize for Creative Innovation
August 01, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Pharma Says Fewer Aflibercept Injections Maintains Vision, Anatomic Improvements In Diabetic Macular Edema
July 31, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the first presentation of two-year (96 weeks) results from the pivotal PHOTON trial of aflibercept 8 mg with 12- and 16-week dosing regimens,...
Via
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
July 17, 2023
Via
Benzinga
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
July 11, 2023
Via
Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
July 07, 2023
Via
Benzinga
Aflibercept 8 mg Two-Year Results from Pivotal PHOTON Trial in Diabetic Macular Edema Presented at ASRS
July 29, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
July 26, 2023
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.
Via
InvestorPlace
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
July 24, 2023
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful.
Via
InvestorPlace
Why Are Kodiak Sciences Shares Trading Lower Today?
July 24, 2023
Kodiak Sciences Inc (NASDAQ: KOD) shares are tumbling after the company released topline results from three Phase 3 studies of tarcocimab tedromer, a novel antibody biopolymer conjugate, for...
Via
Benzinga
Is Regeneron Stock a Buy After a Regulatory Blow?
July 07, 2023
Don't write this company's eulogy too fast.
Via
The Motley Fool
Alnylam Says Single Injection Of RNAi Therapy Cuts Alzheimer's-Linked Proteins By 65%, Stock Soars
July 17, 2023
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced updated interim results for the ongoing single ascending dose portion of the Phase 1 study of ALN-APP for Alzheimer's disease and
Via
Benzinga
3 Pharma Stocks That AI is Loving in July
July 13, 2023
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.
Via
InvestorPlace
3 Biotech Stocks to Buy for Long-Term Gains
July 13, 2023
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
Via
InvestorPlace
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
July 06, 2023
Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.